Prognostic value of Ki67 index in anaplastic oligodendroglial tumours--a translational study of the European Organization for Research and Treatment of Cancer Brain Tumor Group. (Q48659691)

From Wikidata

Jump to navigation Jump to search

scientific article published on 15 February 2012

Language	Label	Description	Also known as
English	Prognostic value of Ki67 index in anaplastic oligodendroglial tumours--a translational study of the European Organization for Research and Treatment of Cancer Brain Tumor Group.	scientific article published on 15 February 2012

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22335622

Prognostic value of Ki67 index in anaplastic oligodendroglial tumours--a translational study of the European Organization for Research and Treatment of Cancer Brain Tumor Group. (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22335622

oligodendrocyte

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Matthias Preusser

1

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22335622

Mathilde Kouwenhoven

5

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22335622

Adelheid Wöhrer

object named as

Adelheid Woehrer

3

0 references

Alba A. Brandes

object named as

Alba A Brandes

9

0 references

author name string

Romana Hoeftberger

2

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22335622

Ellen Gelpi

4

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22335622

Johan M Kros

6

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22335622

Marc Sanson

7

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22335622

Ahmed Idbaih

8

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22335622

Harald Heinzl

10

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22335622

Thierry Gorlia

11

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22335622

Johannes A Hainfellner

12

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22335622

Martin van den Bent

13

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22335622

publication date

15 February 2012

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22335622

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22335622

60

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22335622

6

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22335622

885-894

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22335622

Oligodendrogliomas: molecular biology and treatment.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04134.X

21 January 2018

Correlations between O6-methylguanine DNA methyltransferase promoter methylation status, 1p and 19q deletions, and response to temozolomide in anaplastic and recurrent oligodendroglioma: a prospective GICNO study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04134.X

21 January 2018

IDH1 and IDH2 mutations are prognostic but not predictive for outcome in anaplastic oligodendroglial tumors: a report of the European Organization for Research and Treatment of Cancer Brain Tumor Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04134.X

21 January 2018

MGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: a report from EORTC Brain Tumor Group Study 26951.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04134.X

21 January 2018

Molecular analysis of anaplastic oligodendroglial tumors in a prospective randomized study: A report from EORTC study 26951.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04134.X

21 January 2018

Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04134.X

21 January 2018

Prognostic value of the proliferation-related antigen Ki-67 in oligodendrogliomas.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04134.X

21 January 2018

The prognostic significance of Ki-67 labeling indices for oligodendrogliomas.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04134.X

21 January 2018

Clinicopathologic study of forty-four histologically pure supratentorial oligodendrogliomas.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04134.X

21 January 2018

Proliferation (MIB-1 expression) in oligodendrogliomas: assessment of quantitative methods and prognostic significance.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04134.X

21 January 2018

Proliferating cell nuclear antigen and Ki-67 immunohistochemistry of oligodendrogliomas with special reference to prognosis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04134.X

21 January 2018

Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment [...]

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04134.X

21 January 2018

Interobserver variation of the histopathological diagnosis in clinical trials on glioma: a clinician's perspective

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04134.X

21 January 2018

Panel review of anaplastic oligodendroglioma from European Organization For Research and Treatment of Cancer Trial 26951: assessment of consensus in diagnosis, influence of 1p/19q loss, and correlations with outcome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04134.X

21 January 2018

Genomic aberrations associated with outcome in anaplastic oligodendroglial tumors treated within the EORTC phase III trial 26951

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04134.X

21 January 2018

Ki67 index in intracranial ependymoma: a promising histopathological candidate biomarker.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04134.X

21 January 2018

Ki-67 immunolabeling index is an accurate predictor of outcome in patients with intracranial ependymoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04134.X

21 January 2018

MS-MLPA: an attractive alternative laboratory assay for robust, reliable, and semiquantitative detection of MGMT promoter hypermethylation in gliomas

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04134.X

21 January 2018

A concordance correlation coefficient to evaluate reproducibility

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04134.X

21 January 2018

Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04134.X

21 January 2018

A bootstrap resampling procedure for model building: Application to the cox regression model

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04134.X

21 January 2018

Interobserver variability in determining MIB-1 labeling indices in oligodendrogliomas

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04134.X

21 January 2018

Interobserver reproducibility of MIB-1 labeling index in astrocytic tumors using different counting methods

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04134.X

21 January 2018

Identifiers

10.1111/J.1365-2559.2011.04134.X

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22335622

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22335622

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48659691&oldid=1698528344"